EGM
BBIO icon

Engineers Gate Manager’s BridgeBio Pharma BBIO Stock Holding History

Engineers Gate Manager’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Sell
37,948
-205,781
-84% -$14.4M 0.04% 540
2026
Q1 		$18.1M Buy
243,729
+228,155
+1,465% +$16.5M 0.23% 104
2025
Q4 		$1.19M Buy
15,574
+8,732
+128% +$573K 0.01% 948
2025
Q3 		$355K Sell
6,842
-23,966
-78% -$1.17M ﹤0.01% 1662
2025
Q2 		$1.33M Sell
30,808
-76,635
-71% -$2.79M 0.02% 967
2025
Q1 		$3.71M Buy
+107,443
New +$3.62M 0.06% 442
2024
Q4 		– Sell
-48,604
Closed -$1.24M – 2228
2024
Q3 		$1.24M Sell
48,604
-22,901
-32% -$601K 0.02% 872
2024
Q2 		$1.81M Buy
71,505
+24,910
+53% +$681K 0.04% 601
2024
Q1 		$1.44M Buy
46,595
+16,861
+57% +$573K 0.04% 629
2023
Q4 		$1.2M Buy
29,734
+1,321
+5% +$39.7K 0.03% 705
2023
Q3 		$749K Buy
+28,413
New +$806K 0.03% 877
2023
Q1 		– Sell
-38,136
Closed -$291K – 1652
2022
Q4 		$291K Buy
38,136
+19,428
+104% +$186K 0.02% 1202
2022
Q3 		$186K Sell
18,708
-55,692
-75% -$579K 0.01% 1340
2022
Q2 		$676K Buy
74,400
+58,840
+378% +$492K 0.02% 939
2022
Q1 		$158K Sell
15,560
-31,135
-67% -$320K 0.01% 1657
2021
Q4 		$779K Buy
46,695
+41,424
+786% +$1.75M 0.04% 753
2021
Q3 		$247K Buy
+5,271
New +$283K 0.01% 1310

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Engineers Gate Manager's BBIO Position: Q2 2026 in Review

Engineers Gate Manager reduced its BridgeBio Pharma (BBIO) stake by 84% in Q2 2026, selling an estimated $14.4M and leaving 37,948 shares worth $2.83M. The position accounts for 0.04% of the portfolio, ranked #540.

Engineers Gate Manager first reported a position in BBIO in Q3 2021 and has held it in 17 quarters since. The position peaked at $18.1M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Engineers Gate Manager held 37,948 shares of BridgeBio Pharma worth $2.83M as of Q2 2026.
  • Engineers Gate Manager sold 205,781 BridgeBio Pharma shares in Q2 2026, an estimated $14.4M.
  • BridgeBio Pharma made up 0.04% of Engineers Gate Manager's portfolio in Q2 2026, its #540 holding.
  • Engineers Gate Manager first reported a position in BridgeBio Pharma in Q3 2021 and has held it in 17 quarters since.
  • Engineers Gate Manager's BridgeBio Pharma position peaked at $18.1M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.